Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advanced gastric cancer: Current treatment landscape and future perspectives.

World journal of gastroenterology - 28 Feb 2016

Digklia Antonia, Wagner Anna Dorothea

Abstract excerpt

Gastric cancer currently ranks fourth in cancer-related mortality worldwide. In the western world, it is most often diagnosed at an advanced stage, after becoming metastatic at distant sites. Patients with advanced disease (locally advanced or metastatic) have a somber prognosis, with a median overall survival of 10-12 mo, and palliative chemotherapy is the mainstay of treatment. In recent years, novel approaches...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Discovery

Share to Molecular Diagnostic Techniques

Share to Molecular Targeted Therapy

Share to Palliative Care

Share to Precision Medicine

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 26937129
DOI: 10.3748/wjg.v22.i8.2403
PMCID: PMC4768187

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced gastric cancer: Current treatment landscape and future perspectives.PMID 26937129Read ↗

Current and emerging therapies in unresectable and recurrent gastric cancer.Semantic proximity Read ↗

Current treatment and recent progress in gastric cancer.Semantic proximity Read ↗

Identifying therapeutic targets in gastric cancer: the current status and future direction.Semantic proximity Read ↗

What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future PerspectivesSemantic proximity Read ↗

Molecular Profiling of Gastric Cancer: Toward Personalized Cancer MedicineSemantic proximity Read ↗

Personalized medicine in gastric cancer: Where are we and where are we going?Semantic proximity Read ↗

[Update on gastric cancer. New molecular classifications].Semantic proximity Read ↗

Gastric biomarkers: a global reviewSemantic proximity Read ↗

The genomics and therapeutics of HER2-positive gastric cancer—from trastuzumab and beyondSemantic proximity Read ↗

Translating gastric cancer genomics into targeted therapiesSemantic proximity Read ↗

Antibody-Mediated Therapy in Gastric Cancer: Past, Present, and FutureSemantic proximity Read ↗

Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.